- LILRB2/CD85d/ILT4 Antibody
- R&D Systems, a Bio-Techne Brand
- Pricing InfoSupplier PageView Company Product Page
- MAB2078
- CD85D, ILT-4, ILT4, LIR-2, LIR2, MIR-10, MIR10
- Western Blot, Flow Cytometry, Neutralization, CyTOF-ready
- Unconjugated
- 100 ug (also 25 ug)
- Mouse
- Human
- 287219
- LILRB2/CD85d/ILT4
- IgG2a
- leukocyte immunoglobulin like receptor B2
- Monoclonal
- Lyophilized from a 0.2 µm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS
- Mouse myeloma cell line NS0-derived recombinant human LILRB2/CD85d/ILT4, Gly24-His458, Accession # ACT64556
- LYOPH
- Protein A or G purified from hybridoma culture supernatant
- R&D Systems, a Bio-Techne Brand
- Primary Antibodies
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution
Specifications/Features
Available conjugates: Unconjugated
Specificity: Detects human LILRB2/CD85d/ILT4 in direct ELISAs and Western blots. In direct ELISAs and Western blots, no cross-reactivity with recombinant human (rh) ILT1, rhILT2, rhILT3, rhILT6, rhILT7, rhILT11, rhLIR6 or rhLIR8 is observed